PIAHY vs JNJ: Which Stock is Better?
Side-by-side comparison of Ping An Healthcare and Technology Company Limited and Johnson & Johnson in 2026
PIAHY
Ping An Healthcare and Technology Company Limited
$4.40
JNJ
Johnson & Johnson
$234.18
Key Metrics Comparison
| Metric | PIAHY | JNJ | Winner |
|---|---|---|---|
| Market Cap | $4.68B | $565.22B | JNJ |
| P/E Ratio | 88.00 | 21.26 | JNJ |
| EPS (TTM) | $0.05 | $11.03 | JNJ |
| Revenue Growth | 0.1% | 0.1% | JNJ |
| Gross Margin | 32.4% | 68.0% | JNJ |
Analyze PIAHY
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PIAHY or JNJ a better investment?
Comparing PIAHY and JNJ: Ping An Healthcare and Technology Company Limited has a market cap of $4.68B while Johnson & Johnson has $565.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PIAHY and JNJ?
PIAHY (Ping An Healthcare and Technology Company Limited) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PIAHY or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (21.3x vs 88.0x).
Which is growing faster: PIAHY or JNJ?
JNJ has higher revenue growth at 0.1% vs 0.1% for PIAHY.
Which company is more profitable: PIAHY or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.0% compared to 32.4% for PIAHY.
Which is the larger company: PIAHY or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $565.22B compared to $4.68B for PIAHY.
Should I buy PIAHY or JNJ in 2026?
Both PIAHY and JNJ have investment merit. PIAHY trades at $4.40 while JNJ trades at $234.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PIAHY and JNJ stock?
Key differences: Market Cap ($4.68B vs $565.22B), P/E Ratio (88.0x vs 21.3x), Revenue Growth (0.1% vs 0.1%), Gross Margin (32.4% vs 68.0%).